Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/126498Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Barros, F | - |
| dc.creator | Carneiro, F | - |
| dc.creator | Machado, JC | - |
| dc.creator | Melo, SA | - |
| dc.date.accessioned | 2020-03-02T10:34:12Z | - |
| dc.date.available | 2020-03-02T10:34:12Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.issn | 1664-3224 | - |
| dc.identifier.uri | https://hdl.handle.net/10216/126498 | - |
| dc.description.abstract | Exosomes are a type of extracellular vesicle whose study has grown exponentially in recent years. This led to the understanding that these structures, far from being inert waste by-products of cellular functioning, are active players in intercellular communication mechanisms, including in the interactions between cancer cells and the immune system. The deep comprehension of the crosstalk between tumors and the immune systems of their hosts has gained more and more importance, as immunotherapeutic techniques have emerged as viable options for several types of cancer. In this review, we present a comprehensive, updated, and elucidative review of the current knowledge on the functions played by the exosomes in this crosstalk. The roles of these vesicles in tumor antigen presentation, immune activation, and immunosuppression are approached as the relevant interactions between exosomes and the complement system. The last section of this review is reserved for the exploration of the results from the first phase I to II clinical trials of exosomes-based cell-free cancer vaccines. | - |
| dc.description.sponsorship | The laboratory is supported by FEDER—Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by FCT— Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the projects “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274), (PTDC/BIM-ONC/2754/2014), and (PTDC/BIM-MEC/2834/2014); and by Norte Portugal Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), in the framework of the project NORTE- 01-0145-FEDER-000029. SM is supported by FCT (IF/00543/2013). | - |
| dc.language.iso | eng | - |
| dc.publisher | Frontiers Media | - |
| dc.relation.ispartof | Frontiers in Immunology, vol.9:730 | - |
| dc.rights | openAccess | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | Cancer | - |
| dc.subject | Clinical trials as topic | - |
| dc.subject | Exosomes | - |
| dc.subject | Extracellular vesicles | - |
| dc.subject | Immune response | - |
| dc.title | Exosomes and immune response in cancer: Friends or foes? | - |
| dc.type | Artigo em Revista Científica Internacional | - |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | - |
| dc.identifier.doi | 10.3389/fimmu.2018.00730 | - |
| dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fimmu.2018.00730/full | - |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.3389-fimmu.2018.00730.pdf | 941.61 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
